Antibiotic ProphylaxisTreatment OutcomeDrug Administration ScheduleAntineoplastic Combined Chemotherapy ProtocolsDrug Therapy, CombinationPremedicationTime FactorsProspective StudiesCyclophosphamideAnti-Bacterial AgentsRetrospective StudiesMastectomySurgical Wound InfectionAdministration, OralDouble-Blind MethodSurvival AnalysisCombined Modality TherapyDose-Response Relationship, DrugVincristineFollow-Up StudiesCefazolinRecurrenceAntiemeticsDoxorubicinInfusions, IntravenousEtoposideNeutropeniaClinical Trials as TopicCisplatinPostoperative ComplicationsRisk FactorsSurvival RateAnti-HIV AgentsCranial IrradiationDrug CombinationsHIV InfectionsVomitingFluorouracilDisease-Free SurvivalBreast NeoplasmsRemission InductionChemopreventionRandomized Controlled Trials as TopicPapillomavirus VaccinesAntineoplastic AgentsPrednisoneMethotrexateGenes, BRCA1NauseaOvariectomyOndansetronImmunosuppressive AgentsAntiviral AgentsTreatment FailureBacterial InfectionsIncidenceMastectomy, SubcutaneousTransplantation ConditioningPlatelet TransfusionDisease Models, AnimalDental ProphylaxisRandom AllocationInjections, IntravenousHematopoietic Stem Cell TransplantationGenes, BRCA2Lung NeoplasmsCytarabineDeoxycytidineTransplantation, HomologousMastectomy, SimplePatient ComplianceDroperidolPrognosisTaxoidsPostoperative Nausea and VomitingPaclitaxelOrganophosphonatesGranulocyte Colony-Stimulating FactorVinblastineOvarian NeoplasmsThrombocytopeniaLymphoma, Non-HodgkinAnti-Infective AgentsIfosfamideAntimalarialsAcute DiseaseHemorrhageCarcinoma, Small CellViral LoadSalvage TherapyNeoplasmsBone Marrow TransplantationMetoclopramideInjections, IntramuscularRisk AssessmentVaccinationRifampinAntiretroviral Therapy, Highly ActiveAntifungal AgentsAntibodies, Monoclonal